1-3 of 3
P. Zachée
Close
Sort by
Journal Articles

A Multicentre Phase II Study of the Aminopeptidase Inhibitor, CHR- 2797, in the Treatment of Elderly and/or Previously Treated patients with Acute Myeloid Leukemia.

B. Lowenberg, MD, F. Davies, MD, C. Müller-Tidow, MD, Ulrich Dührsen, A. Burnett, MD, FRCP, P. Zachée, MD, PhD, D. Dierickx, MD, C. Jenkins, MD, P. Sonneveld, MD, M. Jongen-Lavrencic, MD, S. Zweegman, MD, G. Morgan, MD, U. Krug, MD, A. Richardson, PhD, L. Hooftman, MD, G. Ossenkoppele, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 961.
https://doi.org/10.1182/blood.V112.11.961.961
Published: 2008
Journal Articles

Palifermin Treatment in Patients Receiving High Dose Melphalan or BEAM Prior to Autologous Peripheral Blood Stem-Cell Transplantation.

Anne Sonet, MD, G. Bries, MD, N. Meulemans, MD, A. Van Hoof, MD, E. Steel, MD, M. André, MD, A. Ferrant, MD, N. Straetmans, MD, P. Zachée, MD, V. Robin, MD, H. Demuynck, MD, L. Noens, MD, A. Bosly, MD, M. Delforge, MD, D. Bron, MD
Journal: Blood
Blood (2006) 108 (11): 5241.
https://doi.org/10.1182/blood.V108.11.5241.5241
Published: 2006
Journal Articles

Deferasirox (Exjade®, ICL670) Demonstrates Dose-Related Effects on Body Iron Levels Related to Transfusional Iron Intake in Transfusion-Dependent Anemia.

P. Greenberg, G. Dine, A. Ganser, G. Verhoef, L. DeBusscher, G. Quarta, P. Zachée, G. Alimena, M. Jeng, G. Tchernia, I. Gathmann, D. Alberti, B. Rabault
Journal: Blood
Blood (2005) 106 (11): 2694.
https://doi.org/10.1182/blood.V106.11.2694.2694
Published: 2005